205
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Group Sequential Design for Randomized Phase III Trials under the Weibull Model

&
Pages 1190-1205 | Received 05 Aug 2013, Accepted 25 Jul 2014, Published online: 13 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (1)

Monika L. Metzger, Michael P. Link, Amy L. Billett, Jamie Flerlage, John T. LucasJrJr, Belinda N. Mandrell, Matthew J. Ehrhardt, Nickhill Bhakta, Torunn I. Yock, Alison M. Friedmann, Pedro de Alarcon, Sandra Luna-Fineman, Eric Larsen, Sue C. Kaste, Barry Shulkin, Zhaohua Lu, Chen Li, Susan M. Hiniker, Sarah S. Donaldson, Melissa M. Hudson & Matthew J. Krasin. (2021) Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation. Journal of Clinical Oncology 39:20, pages 2276-2283.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.